These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26267657)

  • 1. Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.
    Raina D; Agarwal P; Lee J; Bharti A; McKnight CJ; Sharma P; Kharbanda S; Kufe D
    PLoS One; 2015; 10(8):e0135156. PubMed ID: 26267657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.
    Raina D; Ahmad R; Rajabi H; Panchamoorthy G; Kharbanda S; Kufe D
    Int J Oncol; 2012 May; 40(5):1643-9. PubMed ID: 22200620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells.
    Kosugi M; Ahmad R; Alam M; Uchida Y; Kufe D
    PLoS One; 2011; 6(11):e28234. PubMed ID: 22140559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function.
    Ahmad R; Alam M; Rajabi H; Kufe D
    J Biol Chem; 2012 Jun; 287(25):20866-75. PubMed ID: 22544745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.
    Uchida Y; Raina D; Kharbanda S; Kufe D
    Cancer Biol Ther; 2013 Feb; 14(2):127-34. PubMed ID: 23114713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.
    Leng Y; Cao C; Ren J; Huang L; Chen D; Ito M; Kufe D
    J Biol Chem; 2007 Jul; 282(27):19321-30. PubMed ID: 17500061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
    Raina D; Ahmad R; Joshi MD; Yin L; Wu Z; Kawano T; Vasir B; Avigan D; Kharbanda S; Kufe D
    Cancer Res; 2009 Jun; 69(12):5133-41. PubMed ID: 19491255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.
    Raina D; Kosugi M; Ahmad R; Panchamoorthy G; Rajabi H; Alam M; Shimamura T; Shapiro GI; Supko J; Kharbanda S; Kufe D
    Mol Cancer Ther; 2011 May; 10(5):806-16. PubMed ID: 21421804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.
    Panchamoorthy G; Rehan H; Kharbanda A; Ahmad R; Kufe D
    Hybridoma (Larchmt); 2011 Dec; 30(6):531-5. PubMed ID: 22149278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
    Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D
    Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.
    Bernier AJ; Zhang J; Lillehoj E; Shaw AR; Gunasekara N; Hugh JC
    Mol Cancer; 2011 Jul; 10():93. PubMed ID: 21798038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.
    Kharbanda A; Rajabi H; Jin C; Tchaicha J; Kikuchi E; Wong KK; Kufe D
    Clin Cancer Res; 2014 Nov; 20(21):5423-34. PubMed ID: 25189483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.
    Li Q; Ren J; Kufe D
    Biochem Biophys Res Commun; 2004 Mar; 315(2):471-6. PubMed ID: 14766232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of the human MUC1 oncoprotein.
    Duraisamy S; Kufe T; Ramasamy S; Kufe D
    Int J Oncol; 2007 Sep; 31(3):671-7. PubMed ID: 17671696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.
    Hasegawa M; Sinha RK; Kumar M; Alam M; Yin L; Raina D; Kharbanda A; Panchamoorthy G; Gupta D; Singh H; Kharbanda S; Kufe D
    Clin Cancer Res; 2015 May; 21(10):2338-47. PubMed ID: 25712682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.
    Zhou Y; Rajabi H; Kufe D
    Mol Pharmacol; 2011 May; 79(5):886-93. PubMed ID: 21346142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
    Ramasamy S; Duraisamy S; Barbashov S; Kawano T; Kharbanda S; Kufe D
    Mol Cell; 2007 Sep; 27(6):992-1004. PubMed ID: 17889671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
    Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
    Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1-C activates BMI1 in human cancer cells.
    Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
    Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.